Between October 18–21, this website will move to a new web address (from health.gov to odphp.health.gov). During that time, some functions might not work as expected. We appreciate your patience and understanding as we’re working to make this transition as smooth as possible.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Reduce infections of HPV types prevented by the vaccine in young adults — IID‑07

Status: Baseline only

  
Baseline only
Learn more about our data release schedule

Most Recent Data:
15.1 percent (2013-16)

Target:
8.7 percent

Desired Direction:
Decrease desired

Baseline:
15.1 percent of persons aged 20 to 34 years were positive for at least 1 HPV type prevented by the 9-valent vaccine in 2013-16

See detailed data for this objective

Reduce infections due to human papillomavirus (HPV) types prevented by the 9-valent vaccine in young adults

Target-Setting Method
Percentage point improvement

Data Source:  National Health and Nutrition Examination Survey (NHANES), CDC/NCHS

Learn more about data measurement for this objective

Summary

Every year in the United States, HPV (human papillomavirus) causes many cases of cancer that could be prevented with vaccination. Routine vaccination is recommended at age 11 to 12 years, but many people who need to get the vaccine don’t. Encouraging health care providers to recommend the vaccine is critical for reducing HPV infections.

Topics:  Infectious Disease, Adolescents , Sexually Transmitted Infections, Vaccination

Workgroup: Immunization and Infectious Diseases Workgroup

Other objectives you may be interested in

Browse all Healthy People 2030 objectives